These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36245978)

  • 1. Increased Expression of NXPH4 Correlates with Immune Cell Infiltration and Unfavorable Prognosis in Hepatocellular Carcinoma.
    Tang Q; Chen YM; Shen MM; Dai W; Liang H; Liu JN; Gao J
    J Oncol; 2022; 2022():5005747. PubMed ID: 36245978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of NXPH4 correlates with poor prognosis, metabolic reprogramming, and immune infiltration in colon adenocarcinoma.
    Sun Z; Wang H; Xu Y; Liu Y; Wang L; Zhou R; Zhou R; Ma W; Zhang T
    J Gastrointest Oncol; 2024 Apr; 15(2):641-667. PubMed ID: 38756632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurexophilin 4 is a prognostic biomarker correlated with immune infiltration in bladder cancer.
    Sun X; Xin S; Jin L; Zhang Y; Ye L
    Bioengineered; 2022 May; 13(5):13986-13999. PubMed ID: 35758021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NXPH4 can be used as a biomarker for pan-cancer and promotes colon cancer progression.
    Zhang Z; Wang P; Chen S; Xiang D; Chen J; Huang W; Liu X; Yi T; Wang D; Pu Y; He L; Zhang H
    Aging (Albany NY); 2024 Apr; 16(7):5866-5886. PubMed ID: 38613793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Prognostic Value, Immune Implication and Biological Function of
    Huang Y; Huang S; Ma L; Wang Y; Wang X; Xiao L; Qin W; Li L; Yuan X
    Front Immunol; 2021; 12():723293. PubMed ID: 34899687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Bioinformatics Analysis Identifies Heat Shock Factor 2 as a Prognostic Biomarker Associated With Immune Cell Infiltration in Hepatocellular Carcinoma.
    Fan Y; Hou J; Liu X; Han B; Meng Y; Liu B; Chen F; Shang Y; Cao P; Tan K
    Front Genet; 2021; 12():668516. PubMed ID: 34917120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DTYMK Expression Predicts Prognosis and Chemotherapeutic Response and Correlates with Immune Infiltration in Hepatocellular Carcinoma.
    Guo Y; Luo W; Huang S; Zhao W; Chen H; Ma Y; Ye M; Nie Y; Zhang Y; Huang C; Zhou Q; He X; Chen M
    J Hepatocell Carcinoma; 2021; 8():871-885. PubMed ID: 34377684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forkhead box protein K1‑regulated neurexophilin 4 promotes proliferation, metastasis and glycolysis in colorectal cancer.
    Fan Q; He W; Shang Y
    Exp Ther Med; 2023 Sep; 26(3):434. PubMed ID: 37602314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
    Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
    Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALDH2 is a prognostic biomarker and related with immune infiltrates in HCC.
    Yao S; Yin X; Chen T; Chen W; Zuo H; Bi Z; Zhang X; Jing Y; Pang L; Cheng H
    Am J Cancer Res; 2021; 11(11):5319-5337. PubMed ID: 34873463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Proteins, HMMR, NXPH4, PITX1 and THBS4; A Panel of Biomarkers for Early Diagnosis of Hepatocellular Carcinoma.
    Eun JW; Jang JW; Yang HD; Kim J; Kim SY; Na MJ; Shin E; Ha JW; Jeon S; Ahn YM; Park WS; Nam SW
    J Clin Med; 2022 Apr; 11(8):. PubMed ID: 35456219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Analysis of NABP2 as a Prognostic Biomarker and Its Correlation with Immune Infiltration in Hepatocellular Carcinoma.
    Li B; Liu J; Xu L; Xu Q; Liu Z; Liu T
    J Inflamm Res; 2023; 16():1783-1804. PubMed ID: 37113629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of DTL in Hepatocellular Carcinoma and Its Impact on the Tumor Microenvironment.
    Li Z; Wang R; Qiu C; Cao C; Zhang J; Ge J; Shi Y
    Front Immunol; 2022; 13():834606. PubMed ID: 35392073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma.
    Ding L; Yu Q; Yang S; Yang WJ; Liu T; Xian JR; Tian TT; Li T; Chen W; Wang BL; Pan BS; Zhou J; Fan J; Yang XR; Guo W
    Front Immunol; 2022; 13():831101. PubMed ID: 35371079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAB42 is a Potential Biomarker that Correlates With Immune Infiltration in Hepatocellular Carcinoma.
    Peng H; Du X; Zhang Y
    Front Mol Biosci; 2022; 9():898567. PubMed ID: 35720121
    [No Abstract]   [Full Text] [Related]  

  • 18. NAP1L1 Functions as a Novel Prognostic Biomarker Associated With Macrophages and Promotes Tumor Progression by Influencing the Wnt/β-Catenin Pathway in Hepatocellular Carcinoma.
    Shen B; Zhu W; Liu X; Jiang J
    Front Genet; 2022; 13():876253. PubMed ID: 35664324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Mobility Group AT-Hook 1 Served as a Prognosis Biomarker and Associated with Immune Infiltrate in Hepatocellular Carcinoma.
    Wei YG; Yang CK; Wei ZL; Liao XW; He YF; Zhou X; Huang HS; Lan CL; Han CY; Peng T
    Int J Gen Med; 2022; 15():609-621. PubMed ID: 35058711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EOGT Correlated With Immune Infiltration: A Candidate Prognostic Biomarker for Hepatocellular Carcinoma.
    Shu Y; He L; Gao M; Xiao F; Yang J; Wang S; Wei H; Zhang F; Wei H
    Front Immunol; 2021; 12():780509. PubMed ID: 35069551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.